title: The important role of public-sector research in the United States.
abstract: Between 1970 and 2009, US public institutions participated in the research and development of 153 drugs, including 15 vaccines. Between 1990 and 2007, nearly 10% of all the new drugs and vaccines marketed in the US and about 20% of those representing a therapeutic advance originated in public institutions. The proportion of these drugs that represented a substantial therapeutic advance was over twice that of those produced exclusively by the private sector.
mesh_terms: D000047:Academies and Institutes / Q000191:economics; D035843:Biomedical Research / Q000191:economics; D055808:Drug Discovery / Q000191:economics; D006801:Humans; D017149:Private Sector; D017150:Public Sector / Q000191:economics; D012109:Research Support as Topic; D013997:Time Factors; D014481:United States